No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
347 |
4. Check minimum number of eventsNone |
347 |
5. Include endpointsNone |
347 |
6. Filter based on genotype QC (FinnGen only) |
334 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Blepharospasm
based on the number of shared cases.
Similar with more cases:
- Dystonia
- Extrapyramidal and movement disorders
- Neurological diseases
- Neurological diseases, wide definition
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 334 | 225 | 109 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.05 |
| Median age at first event (years) | 60.76 | 59.31 | 63.73 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 347
- Matched controls
- 3470
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G24.5
ICD-10 Finland
Blepharospasm
+∞
307.7
347
*
N03AE01
ATC
clonazepam; systemic
20.8
151.5
135
103
G24.3
ICD-10 Finland
Spasmodic torticollis
71.5
125.3
69
12
ZX114
NOMESCO Finland
Intramuscular
38.6
119.0
76
25
G51.3
ICD-10 Finland
Clonic hemifacial spasm
379.4
89.2
86
*
3AX01, ,
NOMESCO Finland
238.1
75.5
75
*
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
25.8
68.0
49
22
G24.8
ICD-10 Finland
Other dystonia
212.3
53.6
54
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.5
28.0
224
1186
H04.10
ICD-10 Finland
Dry eye syndrome
4.3
27.3
85
243
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
7.7
23.8
35
50
TCE00
NOMESCO Finland
Therapeutic injection into extraocular muscle
+∞
22.1
21
*
G24.4
ICD-10 Finland
Idiopathic orofacial dystonia
211.6
19.8
20
*
H02.4
ICD-10 Finland
Ptosis of eyelid
6.3
19.7
35
61
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.2
19.3
57
155
G24.9
ICD-10 Finland
Dystonia, unspecified
46.7
18.5
22
5
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
100.3
17.7
19
*
H02.3
ICD-10 Finland
Blepharochalasis
4.1
17.7
53
145
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.5
16.3
42
102
H53.1
ICD-10 Finland
Subjective visual disturbances
4.5
15.9
42
104
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
14.6
50
150
R49.02
ICD-10 Finland
Spasmodic dysphonia
156.3
14.6
15
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.8
14.3
23
36
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.1
13.1
62
228
G51.4
ICD-10 Finland
Facial myokymia
52.1
12.9
15
*
G51.0
ICD-10 Finland
Bell palsy
6.0
12.1
22
39
N05BA01
ATC
diazepam; systemic, rectal
2.7
11.4
70
295
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
20.9
11.2
16
8
M03BX01
ATC
baclofen; systemic
8.4
10.8
23
29
N04AA02
ATC
biperiden; systemic
8.4
10.8
23
29
N03AX12
ATC
[U] gabapentin; oral
2.4
9.7
83
408
M03AX01
ATC
botulinum toxin; parenteral
11.8
9.7
17
15
N05AD01
ATC
haloperidol; systemic
4.5
9.0
22
51
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
5.1
8.9
19
39
N29
ICPC
Neurological sympt/complt other
9.0
8.9
18
21
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
8.9
40
142
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
8.8
53
220
S01GX01
ATC
cromoglicic acid; ophthalmic
2.2
8.8
85
439
N03AF01
ATC
carbamazepine; oral, rectal
3.3
8.8
34
110
AAH60
NOMESCO Finland
Microvascular decompression of cranial nerve
51.3
8.7
10
*
G20
ICD-10 Finland
Parkinson disease
5.0
8.7
19
40
XA402
NOMESCO Finland
ENMG
5.0
8.7
19
40
F01
ICPC
Eye pain
5.1
8.5
18
37
G24
ICD-10 Finland
Dystonia
+∞
8.4
8
*
3AX0X, ,
NOMESCO Finland
+∞
8.4
8
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
8.5
8.2
17
21
A02BC05
ATC
esomeprazole; systemic
1.9
7.8
160
1078
DQD34
NOMESCO Finland
Treatment of spasmodic dysfonia
81.8
7.4
8
*
F95.9
ICD-10 Finland
Tic disorder, unspecified
+∞
7.3
7
*
N05BA04
ATC
oxazepam; oral
2.0
7.3
109
658
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.9
7.3
143
945
N03AF02
ATC
oxcarbazepine; oral
4.1
7.3
20
51
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.5
7.0
24
72
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
14.1
6.9
11
8
N07AA02
ATC
pyridostigmine; systemic
14.1
6.9
11
8
ZX112
NOMESCO Finland
Subcutaneous
4.4
6.8
17
40
N06AB04
ATC
citalopram; systemic
2.0
6.8
91
527
TAC00
NOMESCO Finland
Peripheral nerve block
40.9
6.8
8
*
R25.2
ICD-10 Finland
Cramp and spasm
5.7
6.7
18
33
A02BC02
ATC
pantoprazole; systemic
1.9
6.7
248
1975
N03AX16
ATC
[U] pregabalin
1.9
6.6
98
587
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
4.3
6.6
17
41
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
12.6
6.6
11
9
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.5
6.4
44
194
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
71.1
6.4
7
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.5
6.3
41
177
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
27.2
6.3
8
*
N06AX26
ATC
vortioxetine; oral
3.0
6.2
27
94
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
25
26
10.27
12.95
1.1
1.1
0.28
0.12
nmol/l
—
5
5
140
885
1.98
8.40
2.3
2.0
137.51
185.73
u/l
1.12
134
832
193
1463
1.72
5.73
5.2
6.5
1.21
1.22
mmol/l
0.72
164
1252
8
5
16.32
5.43
1.1
1.0
—
—
—
0
0
264
2262
1.70
4.25
4.6
3.9
14.72
14.86
pmol/l
0.38
236
2039
18
62
3.01
4.23
1.2
1.4
—
—
—
0
0
18
62
3.01
4.23
1.2
1.4
—
—
—
0
0
208
1682
1.59
4.23
4.9
4.8
6.66
6.69
mmol/l
0.09
199
1574
253
2163
1.63
3.91
4.3
4.1
12.20
12.38
mm/h
0.06
239
1979
302
2713
1.87
3.82
16.4
13.3
78.74
78.59
ml/min/173m2
0.04
248
2214
199
1631
1.52
3.53
9.5
8.8
3.77
4.05
e9/l
1.00
173
1433
151
1171
1.51
3.48
2.0
2.0
92.23
95.84
pmol/l
0.35
66
567
13
37
3.61
3.44
1.3
1.1
—
—
—
0
0
296
2670
1.74
3.33
5.6
4.8
1.84
1.93
mu/l
0.76
273
2416
167
1335
1.48
3.26
6.2
5.6
29.25
27.56
%
1.09
159
1255
176
1422
1.48
3.25
4.2
3.8
0.00
0.00
estimate
0.50
41
289
167
1336
1.48
3.24
6.3
5.8
1.21
1.22
mmol/l
1.29
151
1226
78
532
1.60
3.15
4.4
3.9
99.51
171.30
ng/l
0.59
53
421
165
1322
1.47
3.15
6.0
5.3
55.44
57.59
%
1.49
158
1249
178
1450
1.47
3.11
4.2
3.8
0.00
0.00
estimate
-0.00
40
257
176
1432
1.46
3.08
5.4
5.1
0.00
0.00
estimate
-0.00
40
265
42
243
1.83
3.08
5.1
7.1
1.42
1.33
mmol/l
0.20
42
236
46
275
1.78
3.03
1.8
2.3
30.29
31.51
u/l
0.13
38
230
257
2259
1.53
3.01
7.4
7.2
75.60
78.25
u/l
0.59
248
2104
308
2834
1.77
2.90
17.5
14.2
24.61
23.15
mg/l
0.30
245
2220
318
2955
1.91
2.88
19.7
16.7
139.56
139.71
mmol/l
0.47
309
2865
107
801
1.49
2.81
4.5
4.0
0.00
0.00
estimate
-0.00
40
262
32
175
1.91
2.79
1.5
1.4
—
—
—
0
0
131
1023
1.45
2.77
4.1
3.0
—
—
—
0
0
318
2962
1.88
2.75
20.1
16.8
3.94
3.97
mmol/l
1.00
310
2869
15
60
2.57
2.74
1.6
1.5
3.33
8.49
iu/l
—
6
19
146
1168
1.43
2.69
4.0
3.7
21.94
36.51
ng/l
1.89
96
840
129
1014
1.43
2.60
3.3
3.2
2.36
2.36
mmol/l
0.03
116
895
105
796
1.46
2.56
3.8
3.0
0.42
0.58
e6/l
0.54
78
586
148
1208
1.39
2.36
2.0
2.3
83.99
78.82
nmol/l
1.01
134
1070
10
35
2.91
2.22
1.6
1.3
—
—
—
0
0
70
503
1.49
2.22
1.4
1.3
26.07
40.50
iu/ml
0.45
22
168
8
24
3.39
2.19
2.4
2.1
—
—
—
0
0
48
322
1.57
2.08
5.2
9.0
4.88
5.09
kpa
0.70
48
311
48
322
1.57
2.08
5.1
9.1
0.54
1.24
mmol/l
0.46
37
265
48
322
1.57
2.08
5.2
9.0
11.98
11.89
kpa
0.05
48
312
29
173
1.74
1.97
1.2
1.1
117.71
139.19
iu/ml
—
8
77
10
39
2.61
1.95
1.9
1.4
—
—
—
0
0
5
11
4.59
1.95
1.0
1.1
195.38
182.07
pmol/l
—
5
11
5
11
4.59
1.95
1.2
1.3
—
—
—
0
0
9
33
2.77
1.94
6.8
3.6
—
—
—
0
0
34
213
1.66
1.94
1.6
1.6
—
—
—
0
0
47
321
1.54
1.89
2.0
1.9
—
—
—
0
0
300
2807
1.51
1.86
4.5
4.7
5.82
5.97
mmol/l
1.86
268
2538
53
373
1.50
1.86
7.3
6.5
104.55
104.03
mmol/l
0.39
53
373
135
1128
1.32
1.73
4.2
3.9
—
—
—
0
0
111
903
1.34
1.71
3.8
3.7
5.46
8.15
mg/mmol
0.60
62
547
61
450
1.43
1.69
1.3
1.5
—
—
—
0
0
64
479
1.41
1.64
1.2
1.3
5.53
15.34
u/ml
0.98
24
188
288
2692
1.41
1.62
5.6
5.9
39.14
40.04
mmol/mol
1.16
260
2486
87
688
1.35
1.61
2.1
2.0
2.48
3.32
mg/l
3.31
75
592
10
43
2.36
1.60
3.3
2.8
5.60
4.74
e9/l
—
10
43
45
317
1.48
1.59
1.9
1.8
—
—
—
0
0
6
20
3.03
1.58
1.2
1.2
—
—
—
0
0
61
456
1.41
1.58
1.9
1.9
—
—
—
0
0
24
146
1.69
1.55
1.0
1.1
—
—
—
0
0
7
27
2.62
1.52
1.0
1.0
—
—
—
0
0
7
27
2.62
1.52
1.0
1.1
—
—
—
0
0
10
45
2.26
1.47
3.5
3.2
60.50
58.49
%
—
10
45
33
221
1.55
1.47
2.5
3.1
118.71
206.38
ng/l
1.93
28
202
317
3029
1.54
1.46
11.6
10.4
25.07
24.66
u/l
0.20
307
2902
5
16
3.15
1.44
2.2
1.9
—
—
—
0
0
157
1366
1.27
1.42
12.9
14.4
1.12
1.26
inr
1.78
45
399
17
96
1.81
1.41
1.6
1.4
215.30
299.38
ug/g
—
10
54
80
638
1.33
1.39
4.3
4.2
1.02
1.02
kg/l
0.03
14
83
9
41
2.23
1.38
1.1
1.1
—
—
—
0
0
14
75
1.90
1.36
1.6
1.2
—
—
—
0
0
72
568
1.34
1.35
3.7
2.8
2.44
2.45
mmol/l
0.24
65
502
64
496
1.36
1.35
3.5
2.6
0.64
1.02
e6/l
1.22
34
266
71
561
1.33
1.32
1.8
1.7
1373.20
1249.20
nmol/l
0.46
50
417
14
76
1.88
1.31
1.5
1.8
—
—
—
0
0
6
24
2.53
1.31
1.2
1.1
—
—
—
0
0
6
24
2.53
1.31
1.2
1.1
—
—
—
0
0
297
2816
1.38
1.30
4.6
4.6
4.61
4.70
mmol/l
0.89
272
2581
10
48
2.12
1.29
1.3
1.6
—
—
—
0
0
5
18
2.80
1.29
1.0
1.4
—
—
—
0
0
5
18
2.80
1.29
1.0
1.4
—
—
—
0
0
6
25
2.42
1.25
1.2
1.1
—
—
—
0
0
6
25
2.42
1.25
1.2
1.1
—
—
—
0
0
6
25
2.42
1.25
1.2
1.1
—
—
—
0
0
173
1540
1.25
1.24
5.4
6.0
10.33
10.74
umol/l
0.34
165
1449
6
26
2.33
1.19
1.3
1.9
—
—
—
0
0
106
896
1.26
1.19
3.2
3.0
1093.77
1231.90
ng/l
0.19
91
759
323
3119
1.51
1.16
26.0
21.1
40.28
39.92
%
0.59
306
2921
136
1188
1.24
1.13
3.1
2.6
128.94
114.81
ug/l
0.25
129
1085
142
1248
1.23
1.12
5.0
4.3
36.22
35.61
g/l
0.72
135
1169
21
136
1.58
1.11
2.2
2.1
12.55
12.92
nmol/l
0.07
16
123
82
677
1.28
1.11
2.9
2.3
—
—
—
0
0
302
2887
1.36
1.11
5.1
5.1
2.72
2.75
mmol/l
0.33
278
2630
25
169
1.52
1.11
1.4
1.7
—
—
—
0
0
8
41
1.97
1.09
1.3
1.4
—
—
—
0
0
285
2704
1.30
1.09
4.0
4.1
1.30
1.27
mmol/l
0.35
257
2455
57
449
1.32
1.09
3.8
2.8
3.50
2.71
e6/l
0.17
28
222
294
2805
1.32
1.05
4.5
4.5
1.47
1.52
mmol/l
1.49
270
2559
7
35
2.02
1.00
1.3
1.6
—
—
—
0
0
7
35
2.02
1.00
1.0
1.1
—
—
—
0
0
322
3120
1.44
0.98
26.1
21.0
255.25
250.78
e9/l
0.54
314
3033
5
23
2.19
0.98
4.2
3.6
—
45.27
u/ml
—
0
7
5
23
2.19
0.98
1.2
1.3
—
—
—
0
0
27
191
1.45
0.98
2.9
1.9
—
—
—
0
0
179
1628
1.21
0.96
2.6
2.9
—
—
—
0
0
322
3122
1.44
0.96
26.1
21.0
4.47
4.45
e12/l
0.21
314
3024
24
167
1.47
0.95
1.3
1.2
103.73
154.62
u/ml
0.48
24
153
7
37
1.91
0.94
3.0
2.8
—
1071.17
—
0
6
85
720
1.24
0.93
2.4
2.6
326.36
6685.12
umol/l
3.28
76
610
15
94
1.62
0.92
3.5
2.7
—
—
—
0
0
198
1824
1.20
0.91
3.5
3.2
41.68
49.85
u/l
1.13
189
1694
77
647
1.24
0.90
1.8
1.7
0.92
1.19
mg/l
0.61
53
504
106
922
1.22
0.90
2.6
2.5
54.35
54.72
u/l
0.05
97
845
6
29
2.09
0.89
1.3
1.8
—
—
—
0
0
35
266
1.35
0.87
6.5
3.2
1.87
2.13
mmol/l
0.16
30
224
29
214
1.39
0.86
6.2
5.9
8.00
9.44
mmol/l
0.87
29
203
14
89
1.60
0.82
1.6
1.4
—
—
—
0
0
6
32
1.89
0.82
1.3
1.3
—
—
—
0
0
91
788
1.21
0.80
1.5
1.6
1.41
1.35
mmol/l
0.31
72
657
46
369
1.28
0.80
7.0
7.2
—
—
—
0
0
64
535
1.24
0.79
3.4
4.3
21.56
21.44
%
0.01
24
263
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
31
235
1.35
0.79
3.7
3.0
75.71
75.30
ng/l
0.02
26
214
49
397
1.27
0.79
2.3
3.0
0.77
0.75
ug/l
0.02
30
262
16
107
1.52
0.77
1.2
1.7
—
—
—
0
0
16
107
1.52
0.77
1.0
1.2
—
—
—
0
0
6
34
1.78
0.76
1.0
1.4
24.48
33.31
u/l
—
6
27
17
116
1.49
0.75
1.2
1.9
—
—
—
0
0
7
39
1.81
0.73
1.0
1.3
0.49
0.59
nmol/l
—
7
33
16
109
1.49
0.72
1.0
1.2
—
—
—
0
0
7
41
1.72
0.70
1.3
1.5
—
—
—
0
0
11
69
1.61
0.69
1.1
1.3
—
—
—
0
0
7
43
1.64
0.67
1.3
1.6
—
—
—
0
0
16
111
1.46
0.67
2.4
1.8
3.36
2.30
mg/l
—
10
80
15
103
1.48
0.66
1.9
3.6
25.17
25.10
mmol/l
0.04
15
98
27
207
1.33
0.66
3.1
2.0
—
—
—
0
0
13
87
1.51
0.64
1.8
1.7
—
192.00
—
0
5
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
13
89
1.48
0.59
1.1
1.2
—
—
—
0
0
8
53
1.52
0.59
1.3
1.5
—
—
—
0
0
8
53
1.52
0.59
1.3
1.5
—
—
—
0
0
34
275
1.26
0.58
6.4
9.7
124.94
121.17
g/l
0.54
34
269
6
37
1.63
0.56
1.3
1.8
—
—
—
0
0
6
37
1.63
0.56
1.0
1.1
—
—
—
0
0
144
1334
1.14
0.54
2.8
2.5
—
—
—
0
0
78
694
1.16
0.52
1.4
1.6
20.69
21.39
nmol/l
0.15
69
584
6
40
1.51
0.52
5.8
5.5
380.67
361.69
umol/l
—
6
35
12
84
1.44
0.50
1.0
1.1
—
8.43
—
0
13
13
93
1.41
0.49
2.8
1.8
—
—
—
0
0
10
68
1.48
0.47
3.1
1.8
—
—
—
0
0
10
68
1.48
0.47
1.3
1.6
—
—
—
0
0
10
68
1.48
0.47
1.3
1.2
—
—
—
0
0
76
681
1.15
0.46
4.6
4.8
1.75
2.59
ug/l
0.91
71
603
21
165
1.29
0.46
1.3
1.3
—
—
—
0
0
5
32
1.57
0.42
3.0
1.2
—
93.80
—
0
5
0
17
0.00
0.40
0.0
1.9
—
—
—
0
0
0
17
0.00
0.40
0.0
1.9
—
—
—
0
0
9
71
1.27
0.36
1.3
1.5
—
—
—
0
0
6
45
1.34
0.34
1.0
1.4
—
—
—
0
0
6
45
1.34
0.34
1.0
1.4
—
—
—
0
0
6
45
1.34
0.34
1.0
1.4
—
—
—
0
0
6
46
1.31
0.33
1.0
1.4
—
—
—
0
0
6
46
1.31
0.33
1.0
1.4
—
—
—
0
0
6
46
1.31
0.33
1.0
1.4
—
—
—
0
0
10
75
1.34
0.30
1.6
1.7
—
—
—
0
0
37
326
1.15
0.30
2.4
2.7
3.63
6.89
umol/l
4.84
27
286
10
77
1.31
0.26
1.0
1.4
—
—
—
0
0
70
649
1.10
0.26
1.3
1.2
1.36
1.54
u/ml
—
9
183
9
72
1.26
0.26
1.0
1.1
—
—
—
0
0
48
439
1.11
0.23
1.7
1.8
29.57
29.50
s
0.03
48
426
7
95
0.73
0.22
1.4
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
364.00
—
0
5
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
10
80
1.26
0.20
1.8
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
26
234
1.12
0.17
2.2
2.5
72.71
65.77
ml/min/173m2
0.56
14
101
10
83
1.21
0.15
1.3
1.2
—
2.85
—
0
6
12
103
1.17
0.14
2.0
1.5
—
—
—
0
0
66
629
1.06
0.13
1.7
1.7
456.04
454.61
pmol/l
0.01
48
525
36
386
0.92
0.13
4.4
4.4
31.54
32.04
%
0.10
24
251
14
123
1.14
0.12
1.1
1.9
6.77
7.56
g/l
1.45
14
111
14
123
1.14
0.12
1.1
1.9
—
—
—
0
0
14
123
1.14
0.12
1.1
1.9
3.09
3.62
g/l
1.53
14
111
13
116
1.13
0.09
1.2
1.9
2.75
3.01
g/l
0.52
13
104
11
97
1.14
0.09
1.1
2.0
0.00
0.06
g/l
0.49
11
89
5
64
0.78
0.08
1.2
1.2
—
13.73
—
0
6
6
74
0.81
0.07
1.0
1.4
—
—
—
0
0
8
78
1.03
0.07
1.4
1.2
—
12.18
—
0
18
12
109
1.10
0.06
1.7
2.1
0.28
0.41
g/l
0.15
12
94
94
921
1.03
0.06
2.8
3.1
27.76
30.12
u/l
0.75
88
875
10
90
1.11
0.05
1.0
2.0
0.00
0.00
g/l
—
10
83
50
486
1.03
0.05
1.4
1.5
—
—
—
0
0
20
189
1.06
0.05
11.7
9.5
24.27
24.54
mmol/l
0.08
20
181
30
310
0.96
0.03
4.5
3.4
—
—
—
0
0
10
92
1.09
0.03
1.0
2.0
0.00
0.00
g/l
—
10
84
34
333
1.02
0.01
3.2
3.9
2.68
39.62
ug/l
0.93
27
279
10
102
0.98
0.00
1.1
1.9
41.56
38.21
g/l
—
10
90
23
228
1.01
0.00
2.0
1.7
—
—
—
0
0
24
235
1.02
0.00
5.8
2.5
4.52
4.31
kpa
0.30
24
227
7
77
0.91
-0.00
1.4
1.2
—
2.38
—
0
13
0
9
0.00
-0.00
0.0
1.7
—
63.11
—
0
9
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
-0.00
0.0
2.6
—
111.14
—
0
7
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
-0.00
0.0
1.0
—
139.17
—
0
6
0
8
0.00
-0.00
0.0
1.9
—
104.88
—
0
8
0
5
0.00
-0.00
0.0
2.2
—
1.20
—
0
5
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
96
0.94
-0.00
1.4
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
1300.63
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
25.62
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
69
0.87
-0.00
1.8
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: G6_BLEPHAROSPASM – Blepharospasm
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).